Jade Biosciences, Inc. (JBIO)

NASDAQ: JBIO · Real-Time Price · USD

19.90

+0.05 (0.25%)

Sep 4, 2026, 4:00 PM EDT - Market closed

Jade Biosciences Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-164.74	-113.54	-64.48
Net Income	-124.44	-100.14	-93.96
Earnings Per Share	-2.34	-3.19	-29.78
EPS Growth	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	461.21	336.16	69.39
Total Debt	1.39	0.85	107.6
Net Cash (Debt)	459.82	335.31	-38.21
Net Cash Growth	-	-	-
Net Cash Per Share	8.66	10.69	-12.11

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-123.51	-94.69	-45.23
Capital Expenditures	-0.06	-0.2	-
Free Cash Flow	-123.57	-94.89	-45.23
Free Cash Flow Growth	-	-	-

Valuation

Selected indicators aren't available for this stock.